Home/Filings/4/0001455244-17-000037
4//SEC Filing

SCHEDER-BIESCHIN MAX 4

Accession 0001455244-17-000037

CIK 0001549084other

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 1:26 PM ET

Size

5.2 KB

Accession

0001455244-17-000037

Insider Transaction Report

Form 4
Period: 2017-09-07
SCHEDER-BIESCHIN MAX
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2017-09-07$1.13/sh+10,000$11,30032,371 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.11 to $1.14, inclusive. The reporting person undertakes to provide to Ekso Bionics Holdings, Inc., any security holder of Ekso Bionics Holdings, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Issuer

EKSO BIONICS HOLDINGS, INC.

CIK 0001549084

Entity typeother

Related Parties

1
  • filerCIK 0001342549

Filing Metadata

Form type
4
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 1:26 PM ET
Size
5.2 KB